Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | Inhibition | = | 40 | % | 10.1016/S0960-894X(97)00029-2 |
NPT450 | Organism | Meloidogyne incognita | Meloidogyne incognita | EC50 | = | 4 | ug/ml | 12502310 |
NPT4373 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Bos taurus | Ki | = | 1810 | nM | 1517739 |
NPT944 | Individual Protein | Glucose transporter | Leishmania mexicana | Inhibition | = | -0.34 | % | PubChem BioAssay data set |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED25 | = | 44.4 | mg/kg | 20163893 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED25 | = | 127.4 | mg/kg | 20163893 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED25 | = | 73.4 | mg/kg | 9461661 |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | EC50 | = | 18000 | nM | 26317881 |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | EC50 | = | 15000 | nM | 26317881 |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | > | 400000 | nM | 11858761 |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | > | 400000 | nM | 16124769 |
NPT1156 | Individual Protein | Intestinal alkaline phosphatase | Bos taurus | IC50 | > | 400000 | nM | 19704125 |
NPT2 | Others | Unspecified | IC50 | = | 41000 | nM | 19704125 | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 26679.5 | nM | PubChem BioAssay data set | |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | LD99 | = | 1.6 | ug/ml | 24809953 |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | LD99 | > | 100 | ug/ml | 24870926 |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | LD99 | = | 0.78 | ug/ml | 24870926 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 13 | PubChem BioAssay data set | ||
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | LD99 | = | 0.71 | nM | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | IC50 | = | 13300 | nM | 10.6019/CHEMBL1201861 | |
NPT2 | Others | Unspecified | Ki | = | 93000 | nM | 23434131 | |
NPT2 | Others | Unspecified | IC50 | = | 256000 | nM | 9584399 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Inhibition | = | 11 | % | 17336532 |
NPT2 | Others | Unspecified | Ki | = | 47000 | nM | 22220635 | |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | LD99 | = | 0.66 | nM | 18163588 |
NPT6229 | Organism | Heteropogon contortus | Heteropogon contortus | LD99 | = | 1.6 | ug/ml | 22834923 |
NPT333 | Cell Line | CEM | Homo sapiens | IC50 | > | 250000 | nM | 23957453 |
NPT4923 | Organism | Trichostrongylus colubriformis | Trichostrongylus colubriformis | EC100 | = | 10 | ppm | PubChem BioAssay data set |
NPT3503 | Organism | Nippostrongylus brasiliensis | Nippostrongylus brasiliensis | Activity | = | 100 | % | 12444686 |
NPT3503 | Organism | Nippostrongylus brasiliensis | Nippostrongylus brasiliensis | Activity | = | 100 | % | 9917283 |
NPT942 | Individual Protein | Glucose transporter | Homo sapiens | Inhibition | = | -0.53 | % | 23398362 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 65.3 | % | 15270558 |
NPT32 | Organism | Mus musculus | Mus musculus | LD50 | = | 136 | mg/kg | 12502308 |
NPT32 | Organism | Mus musculus | Mus musculus | LD50 | = | 15 | mg/kg | 12502308 |
NPT2 | Others | Unspecified | Activity | = | 33 | % | 26259802 | |
NPT3503 | Organism | Nippostrongylus brasiliensis | Nippostrongylus brasiliensis | EC50 | = | 210 | nM | 22194678 |
NPT2 | Others | Unspecified | Ki | = | 30500 | nM | 19995919 | |
NPT2 | Others | Unspecified | IC50 | = | 23200 | nM | 19738019 | |
NPT2 | Others | Unspecified | IC50 | = | 62900 | nM | 20855744 | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 3768.6 | nM | DrugMatrix in vitro pharmacology data | |
NPT6302 | Individual Protein | Alkaline phosphatase placental type | Homo sapiens | IC50 | > | 400000 | nM | 15916425 |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 8492.1 | nM | 18676881 | |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | Ki | = | 16000 | nM | 18183025 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 1 | % | 10.6019/CHEMBL1201861 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 0 | % | 15974618 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 2 | % | 15974618 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 1 | % | 15974618 |
NPT450 | Organism | Meloidogyne incognita | Meloidogyne incognita | EC100 | > | 20 | ug/ml | 22360613 |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | IC50 | > | 5000 | nM | 23265253 |
NPT1149 | Individual Protein | Phospholipase A-2-activating protein | Homo sapiens | IC50 | > | 5000 | nM | 22680914 |
NPT943 | Individual Protein | Hexose transporter 1 | Plasmodium falciparum | Inhibition | = | 2.58 | % | 25286284 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 93 | % | 24479418 |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | LD99 | = | 0.66 | nM | 16499324 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 5 | % | 24479418 |
NPT6302 | Individual Protein | Alkaline phosphatase placental type | Homo sapiens | IC50 | > | 400000 | nM | 22329624 |
NPT2 | Others | Unspecified | Ki | = | 4000000 | nM | 22037378 | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 8199.5 | nM | 23398362 | |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 206000 | nM | 9214729 |
NPT4373 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Bos taurus | IC50 | = | 19210 | nM | 21215647 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 13 | 17595133 | ||
NPT2 | Others | Unspecified | Ratio IC50 | = | 13 | 17286431 | ||
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 88.2 | % | 18006320 |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 631 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Activity | = | 33 | % | 15646539 | |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | > | 5000 | nM | 17279798 |
NPT2 | Others | Unspecified | IC50 | = | 4392 | nM | 17958396 | |
NPT2 | Others | Unspecified | Ki | = | 2703 | nM | 17958396 | |
NPT1156 | Individual Protein | Intestinal alkaline phosphatase | Bos taurus | IC50 | > | 400000 | nM | 18838598 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 250000 | nM | Open TG-GATES in vivo data: Biochemistry |
NPT306 | Cell Line | PC-3 | Homo sapiens | FC | = | 1.028 | 25597012 | |
NPT2 | Others | Unspecified | Activity | = | 88 | % | 18271551 | |
NPT4924 | Organism | Haemonchus contortus | Haemonchus contortus | EC100 | = | 0.32 | ppm | 10.1016/S0261-2194(02)00175-8 |
NPT6302 | Individual Protein | Alkaline phosphatase placental type | Homo sapiens | IC50 | > | 400000 | nM | 17190444 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC469974 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.7429 | Intermediate Similarity | NPC7067 |
0.6944 | Remote Similarity | NPC322040 |
0.6931 | Remote Similarity | NPC231986 |
0.6907 | Remote Similarity | NPC299134 |
0.6897 | Remote Similarity | NPC164802 |
0.6837 | Remote Similarity | NPC98976 |
0.6818 | Remote Similarity | NPC471319 |
0.6818 | Remote Similarity | NPC471320 |
0.6804 | Remote Similarity | NPC244738 |
0.6796 | Remote Similarity | NPC474088 |
0.6768 | Remote Similarity | NPC271642 |
0.6727 | Remote Similarity | NPC108339 |
0.6697 | Remote Similarity | NPC473661 |
0.6636 | Remote Similarity | NPC469330 |
0.6635 | Remote Similarity | NPC104070 |
0.6535 | Remote Similarity | NPC325662 |
0.6535 | Remote Similarity | NPC98269 |
0.6504 | Remote Similarity | NPC288232 |
0.6476 | Remote Similarity | NPC119677 |
0.6471 | Remote Similarity | NPC12857 |
0.6455 | Remote Similarity | NPC470926 |
0.6415 | Remote Similarity | NPC169016 |
0.635 | Remote Similarity | NPC89489 |
0.6349 | Remote Similarity | NPC264580 |
0.6316 | Remote Similarity | NPC472258 |
0.6311 | Remote Similarity | NPC475013 |
0.6296 | Remote Similarity | NPC258046 |
0.6275 | Remote Similarity | NPC139658 |
0.6263 | Remote Similarity | NPC219246 |
0.6239 | Remote Similarity | NPC329375 |
0.6238 | Remote Similarity | NPC113000 |
0.6238 | Remote Similarity | NPC112609 |
0.6238 | Remote Similarity | NPC122327 |
0.6216 | Remote Similarity | NPC316108 |
0.6214 | Remote Similarity | NPC468984 |
0.621 | Remote Similarity | NPC476048 |
0.6194 | Remote Similarity | NPC300315 |
0.619 | Remote Similarity | NPC475573 |
0.619 | Remote Similarity | NPC313673 |
0.619 | Remote Similarity | NPC475289 |
0.614 | Remote Similarity | NPC329430 |
0.6122 | Remote Similarity | NPC52330 |
0.6107 | Remote Similarity | NPC283130 |
0.6107 | Remote Similarity | NPC328683 |
0.6103 | Remote Similarity | NPC194857 |
0.6103 | Remote Similarity | NPC32858 |
0.61 | Remote Similarity | NPC229235 |
0.6091 | Remote Similarity | NPC53492 |
0.6091 | Remote Similarity | NPC473031 |
0.6084 | Remote Similarity | NPC470822 |
0.6083 | Remote Similarity | NPC474695 |
0.608 | Remote Similarity | NPC296163 |
0.6058 | Remote Similarity | NPC290638 |
0.6053 | Remote Similarity | NPC71140 |
0.6042 | Remote Similarity | NPC470824 |
0.6016 | Remote Similarity | NPC192209 |
0.6015 | Remote Similarity | NPC52764 |
0.5984 | Remote Similarity | NPC101139 |
0.5982 | Remote Similarity | NPC470877 |
0.5966 | Remote Similarity | NPC291610 |
0.5966 | Remote Similarity | NPC239854 |
0.5959 | Remote Similarity | NPC283783 |
0.5952 | Remote Similarity | NPC187036 |
0.5938 | Remote Similarity | NPC285926 |
0.5938 | Remote Similarity | NPC14672 |
0.5938 | Remote Similarity | NPC315276 |
0.5929 | Remote Similarity | NPC78041 |
0.5929 | Remote Similarity | NPC121872 |
0.5929 | Remote Similarity | NPC159178 |
0.5929 | Remote Similarity | NPC74936 |
0.5929 | Remote Similarity | NPC471307 |
0.5929 | Remote Similarity | NPC141139 |
0.5929 | Remote Similarity | NPC209764 |
0.5926 | Remote Similarity | NPC478079 |
0.5877 | Remote Similarity | NPC226438 |
0.5865 | Remote Similarity | NPC276699 |
0.5842 | Remote Similarity | NPC5324 |
0.5839 | Remote Similarity | NPC226662 |
0.5833 | Remote Similarity | NPC475915 |
0.5822 | Remote Similarity | NPC128237 |
0.5822 | Remote Similarity | NPC83790 |
0.582 | Remote Similarity | NPC143516 |
0.582 | Remote Similarity | NPC473418 |
0.5812 | Remote Similarity | NPC317400 |
0.5809 | Remote Similarity | NPC476950 |
0.5804 | Remote Similarity | NPC305602 |
0.5804 | Remote Similarity | NPC17497 |
0.5804 | Remote Similarity | NPC471638 |
0.5793 | Remote Similarity | NPC471680 |
0.5776 | Remote Similarity | NPC474974 |
0.5776 | Remote Similarity | NPC471309 |
0.5773 | Remote Similarity | NPC45255 |
0.5772 | Remote Similarity | NPC474973 |
0.5772 | Remote Similarity | NPC130898 |
0.5772 | Remote Similarity | NPC474804 |
0.5758 | Remote Similarity | NPC476990 |
0.5758 | Remote Similarity | NPC200964 |
0.5758 | Remote Similarity | NPC302169 |
0.5755 | Remote Similarity | NPC207428 |
0.575 | Remote Similarity | NPC474582 |
0.5726 | Remote Similarity | NPC161972 |
0.5726 | Remote Similarity | NPC303045 |
0.5725 | Remote Similarity | NPC187231 |
0.5714 | Remote Similarity | NPC202521 |
0.5714 | Remote Similarity | NPC203076 |
0.57 | Remote Similarity | NPC36440 |
0.5691 | Remote Similarity | NPC476198 |
0.5685 | Remote Similarity | NPC322878 |
0.568 | Remote Similarity | NPC473676 |
0.5678 | Remote Similarity | NPC25565 |
0.5672 | Remote Similarity | NPC252878 |
0.5672 | Remote Similarity | NPC182570 |
0.5672 | Remote Similarity | NPC265605 |
0.5672 | Remote Similarity | NPC48564 |
0.5664 | Remote Similarity | NPC477557 |
0.5656 | Remote Similarity | NPC474430 |
0.5652 | Remote Similarity | NPC78154 |
0.5645 | Remote Similarity | NPC471447 |
0.5643 | Remote Similarity | NPC325479 |
0.5639 | Remote Similarity | NPC326232 |
0.5638 | Remote Similarity | NPC13470 |
0.563 | Remote Similarity | NPC46427 |
0.563 | Remote Similarity | NPC475439 |
0.563 | Remote Similarity | NPC474082 |
0.563 | Remote Similarity | NPC473501 |
0.563 | Remote Similarity | NPC175726 |
0.563 | Remote Similarity | NPC6975 |
0.563 | Remote Similarity | NPC311242 |
0.5614 | Remote Similarity | NPC12429 |
0.5612 | Remote Similarity | NPC9856 |
0.5603 | Remote Similarity | NPC245259 |
0.56 | Remote Similarity | NPC55529 |
0.56 | Remote Similarity | NPC321617 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC469974 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD488 | Approved |
1.0 | High Similarity | NPD489 | Approved |
0.7719 | Intermediate Similarity | NPD2543 | Discontinued |
0.7627 | Intermediate Similarity | NPD2340 | Discontinued |
0.7429 | Intermediate Similarity | NPD197 | Approved |
0.7429 | Intermediate Similarity | NPD199 | Approved |
0.7328 | Intermediate Similarity | NPD5064 | Approved |
0.7328 | Intermediate Similarity | NPD5063 | Approved |
0.7241 | Intermediate Similarity | NPD480 | Approved |
0.7054 | Intermediate Similarity | NPD1396 | Approved |
0.7048 | Intermediate Similarity | NPD297 | Approved |
0.7048 | Intermediate Similarity | NPD9 | Approved |
0.7 | Intermediate Similarity | NPD6105 | Discontinued |
0.6949 | Remote Similarity | NPD2810 | Discontinued |
0.6944 | Remote Similarity | NPD243 | Approved |
0.6944 | Remote Similarity | NPD8 | Approved |
0.6916 | Remote Similarity | NPD2998 | Approved |
0.6916 | Remote Similarity | NPD2997 | Approved |
0.6916 | Remote Similarity | NPD3000 | Approved |
0.6911 | Remote Similarity | NPD5961 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD477 | Phase 1 |
0.6893 | Remote Similarity | NPD5178 | Approved |
0.6893 | Remote Similarity | NPD2538 | Approved |
0.6893 | Remote Similarity | NPD2539 | Approved |
0.6884 | Remote Similarity | NPD3987 | Approved |
0.6884 | Remote Similarity | NPD3988 | Approved |
0.6869 | Remote Similarity | NPD603 | Approved |
0.6864 | Remote Similarity | NPD753 | Approved |
0.6842 | Remote Similarity | NPD1028 | Approved |
0.6842 | Remote Similarity | NPD1026 | Approved |
0.6832 | Remote Similarity | NPD5372 | Approved |
0.6832 | Remote Similarity | NPD5371 | Approved |
0.6827 | Remote Similarity | NPD9505 | Clinical (unspecified phase) |
0.6804 | Remote Similarity | NPD9728 | Phase 1 |
0.6789 | Remote Similarity | NPD6548 | Approved |
0.6789 | Remote Similarity | NPD6549 | Approved |
0.6783 | Remote Similarity | NPD1268 | Approved |
0.6783 | Remote Similarity | NPD1269 | Approved |
0.6772 | Remote Similarity | NPD2143 | Discontinued |
0.6762 | Remote Similarity | NPD5252 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD6562 | Approved |
0.675 | Remote Similarity | NPD6561 | Approved |
0.6733 | Remote Similarity | NPD1051 | Approved |
0.6733 | Remote Similarity | NPD1053 | Approved |
0.6733 | Remote Similarity | NPD508 | Approved |
0.6733 | Remote Similarity | NPD1052 | Approved |
0.6733 | Remote Similarity | NPD507 | Approved |
0.6729 | Remote Similarity | NPD9351 | Phase 3 |
0.6729 | Remote Similarity | NPD9348 | Approved |
0.6729 | Remote Similarity | NPD9349 | Approved |
0.6729 | Remote Similarity | NPD9350 | Approved |
0.6721 | Remote Similarity | NPD2464 | Approved |
0.6721 | Remote Similarity | NPD2463 | Approved |
0.6721 | Remote Similarity | NPD2467 | Approved |
0.6667 | Remote Similarity | NPD157 | Clinical (unspecified phase) |
0.6613 | Remote Similarity | NPD483 | Approved |
0.6609 | Remote Similarity | NPD154 | Discontinued |
0.6604 | Remote Similarity | NPD304 | Approved |
0.6604 | Remote Similarity | NPD305 | Approved |
0.6565 | Remote Similarity | NPD6729 | Phase 2 |
0.6549 | Remote Similarity | NPD6498 | Approved |
0.6549 | Remote Similarity | NPD6499 | Approved |
0.6535 | Remote Similarity | NPD4323 | Clinical (unspecified phase) |
0.6525 | Remote Similarity | NPD2206 | Approved |
0.6525 | Remote Similarity | NPD5614 | Approved |
0.6525 | Remote Similarity | NPD2207 | Approved |
0.6525 | Remote Similarity | NPD5613 | Approved |
0.6496 | Remote Similarity | NPD959 | Discontinued |
0.6484 | Remote Similarity | NPD3623 | Clinical (unspecified phase) |
0.6484 | Remote Similarity | NPD3622 | Clinical (unspecified phase) |
0.6471 | Remote Similarity | NPD296 | Approved |
0.6471 | Remote Similarity | NPD295 | Approved |
0.6471 | Remote Similarity | NPD293 | Approved |
0.6466 | Remote Similarity | NPD5655 | Clinical (unspecified phase) |
0.6466 | Remote Similarity | NPD793 | Approved |
0.6462 | Remote Similarity | NPD3894 | Discontinued |
0.6457 | Remote Similarity | NPD5187 | Clinical (unspecified phase) |
0.6455 | Remote Similarity | NPD7160 | Approved |
0.6444 | Remote Similarity | NPD5780 | Phase 2 |
0.6422 | Remote Similarity | NPD5656 | Clinical (unspecified phase) |
0.6415 | Remote Similarity | NPD785 | Approved |
0.6412 | Remote Similarity | NPD3588 | Discontinued |
0.6385 | Remote Similarity | NPD4985 | Clinical (unspecified phase) |
0.6381 | Remote Similarity | NPD4169 | Approved |
0.6381 | Remote Similarity | NPD4170 | Approved |
0.6381 | Remote Similarity | NPD4701 | Clinical (unspecified phase) |
0.6373 | Remote Similarity | NPD4147 | Approved |
0.6373 | Remote Similarity | NPD4144 | Approved |
0.6348 | Remote Similarity | NPD1946 | Clinical (unspecified phase) |
0.6339 | Remote Similarity | NPD735 | Approved |
0.6339 | Remote Similarity | NPD736 | Approved |
0.6333 | Remote Similarity | NPD2242 | Phase 1 |
0.6328 | Remote Similarity | NPD1947 | Approved |
0.6321 | Remote Similarity | NPD831 | Approved |
0.6321 | Remote Similarity | NPD830 | Approved |
0.6294 | Remote Similarity | NPD5570 | Discontinued |
0.6286 | Remote Similarity | NPD472 | Approved |
0.6286 | Remote Similarity | NPD3035 | Approved |
0.6279 | Remote Similarity | NPD1948 | Approved |
0.6271 | Remote Similarity | NPD2937 | Phase 1 |
0.6271 | Remote Similarity | NPD2939 | Approved |
0.6262 | Remote Similarity | NPD9395 | Approved |
0.6261 | Remote Similarity | NPD1724 | Approved |
0.626 | Remote Similarity | NPD1265 | Approved |
0.626 | Remote Similarity | NPD1267 | Approved |
0.626 | Remote Similarity | NPD2056 | Discontinued |
0.6242 | Remote Similarity | NPD4566 | Approved |
0.6242 | Remote Similarity | NPD4567 | Approved |
0.624 | Remote Similarity | NPD4801 | Phase 1 |
0.6239 | Remote Similarity | NPD1540 | Approved |
0.6238 | Remote Similarity | NPD9592 | Approved |
0.6238 | Remote Similarity | NPD9589 | Approved |
0.6238 | Remote Similarity | NPD80 | Approved |
0.6238 | Remote Similarity | NPD9593 | Approved |
0.6238 | Remote Similarity | NPD9591 | Approved |
0.6238 | Remote Similarity | NPD9594 | Approved |
0.6238 | Remote Similarity | NPD9590 | Approved |
0.6238 | Remote Similarity | NPD9588 | Approved |
0.6228 | Remote Similarity | NPD5963 | Phase 2 |
0.6228 | Remote Similarity | NPD5964 | Phase 2 |
0.6214 | Remote Similarity | NPD2088 | Approved |
0.6214 | Remote Similarity | NPD2087 | Approved |
0.6214 | Remote Similarity | NPD2022 | Approved |
0.6212 | Remote Similarity | NPD1950 | Approved |
0.6212 | Remote Similarity | NPD1949 | Approved |
0.6207 | Remote Similarity | NPD787 | Suspended |
0.6204 | Remote Similarity | NPD2208 | Approved |
0.6204 | Remote Similarity | NPD2205 | Approved |
0.6194 | Remote Similarity | NPD3424 | Clinical (unspecified phase) |
0.619 | Remote Similarity | NPD6660 | Discontinued |
0.6186 | Remote Similarity | NPD1542 | Approved |
0.6182 | Remote Similarity | NPD587 | Approved |
0.6182 | Remote Similarity | NPD588 | Approved |
0.6174 | Remote Similarity | NPD1672 | Phase 2 |
0.617 | Remote Similarity | NPD4469 | Phase 3 |
0.6167 | Remote Similarity | NPD3459 | Approved |
0.6164 | Remote Similarity | NPD8001 | Phase 3 |
0.616 | Remote Similarity | NPD1813 | Discontinued |
0.616 | Remote Similarity | NPD7062 | Discontinued |
0.6154 | Remote Similarity | NPD1795 | Discontinued |
0.6147 | Remote Similarity | NPD3099 | Discontinued |
0.6143 | Remote Similarity | NPD1884 | Approved |
0.614 | Remote Similarity | NPD5554 | Approved |
0.6132 | Remote Similarity | NPD4026 | Approved |
0.6132 | Remote Similarity | NPD4027 | Approved |
0.6127 | Remote Similarity | NPD3508 | Approved |
0.6126 | Remote Similarity | NPD771 | Phase 3 |
0.6115 | Remote Similarity | NPD4410 | Clinical (unspecified phase) |
0.6115 | Remote Similarity | NPD4411 | Phase 1 |
0.6107 | Remote Similarity | NPD478 | Approved |
0.6106 | Remote Similarity | NPD4408 | Approved |
0.6106 | Remote Similarity | NPD4407 | Approved |
0.6106 | Remote Similarity | NPD6690 | Approved |
0.6106 | Remote Similarity | NPD4405 | Approved |
0.6103 | Remote Similarity | NPD6076 | Approved |
0.6103 | Remote Similarity | NPD6075 | Approved |
0.6102 | Remote Similarity | NPD707 | Approved |
0.6095 | Remote Similarity | NPD589 | Approved |
0.6095 | Remote Similarity | NPD590 | Approved |
0.6094 | Remote Similarity | NPD152 | Suspended |
0.6091 | Remote Similarity | NPD783 | Approved |
0.6091 | Remote Similarity | NPD781 | Approved |
0.6091 | Remote Similarity | NPD782 | Approved |
0.6091 | Remote Similarity | NPD780 | Approved |
0.6087 | Remote Similarity | NPD3908 | Approved |
0.6087 | Remote Similarity | NPD532 | Approved |
0.6071 | Remote Similarity | NPD4728 | Approved |
0.6068 | Remote Similarity | NPD1796 | Phase 3 |
0.6066 | Remote Similarity | NPD8010 | Approved |
0.6066 | Remote Similarity | NPD1721 | Clinical (unspecified phase) |
0.6066 | Remote Similarity | NPD8009 | Approved |
0.6063 | Remote Similarity | NPD4660 | Discontinued |
0.6055 | Remote Similarity | NPD5916 | Discontinued |
0.6053 | Remote Similarity | NPD1080 | Approved |
0.6053 | Remote Similarity | NPD4545 | Approved |
0.6053 | Remote Similarity | NPD4542 | Approved |
0.605 | Remote Similarity | NPD5103 | Approved |
0.6047 | Remote Similarity | NPD3466 | Discontinued |
0.6036 | Remote Similarity | NPD5675 | Discontinued |
0.6036 | Remote Similarity | NPD3345 | Approved |
0.6034 | Remote Similarity | NPD528 | Clinical (unspecified phase) |
0.6018 | Remote Similarity | NPD4543 | Discontinued |
0.6016 | Remote Similarity | NPD2537 | Clinical (unspecified phase) |
0.6016 | Remote Similarity | NPD3581 | Discontinued |
0.6016 | Remote Similarity | NPD6235 | Approved |
0.6016 | Remote Similarity | NPD6236 | Approved |
0.6015 | Remote Similarity | NPD2294 | Approved |
0.6 | Remote Similarity | NPD4636 | Approved |
0.6 | Remote Similarity | NPD4165 | Phase 2 |
0.6 | Remote Similarity | NPD9563 | Approved |
0.6 | Remote Similarity | NPD3509 | Approved |
0.6 | Remote Similarity | NPD3066 | Phase 2 |
0.6 | Remote Similarity | NPD3510 | Approved |
0.6 | Remote Similarity | NPD79 | Approved |
0.6 | Remote Similarity | NPD9564 | Approved |
0.5985 | Remote Similarity | NPD5299 | Approved |
0.5984 | Remote Similarity | NPD5253 | Approved |
0.5984 | Remote Similarity | NPD2622 | Approved |
0.597 | Remote Similarity | NPD2585 | Clinical (unspecified phase) |
0.5969 | Remote Similarity | NPD18 | Approved |
PubChem CID   | 26879 |
ChEMBL   | CHEMBL1454 |
ZINC   |
Molecular Weight:   | 204.07 |
ALogP:   | 0.5047 |
MLogP:   | 2.34 |
XLogP:   | 3.905 |
# Rotatable Bonds:   | 1 |
Polar Surface Area:   | 40.9 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 14 |